Sattva Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 30-06-2024
- Paid Up Capital ₹ 0.10 M
as on 30-06-2024
- Company Age 40 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 2534.97%
(FY 2021)
- Profit 1344.85%
(FY 2021)
- Ebitda 1087.87%
(FY 2021)
- Net Worth 121.54%
(FY 2021)
- Total Assets 127.13%
(FY 2021)
About Sattva Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shyam Ruia and Chandra Ruia serve as directors at the Company.
- CIN/LLPIN
U24230MH1984PTC031774
- Company No.
031774
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jan 1984
- Date of AGM
31 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sattva Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyam Ruia  | Director | 10-Aug-2018 | Current |
| Chandra Ruia | Director | 10-Aug-2018 | Current |
Financial Performance of Sattva Pharmaceuticals.
Sattva Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 2534.97% increase. The company also saw a substantial improvement in profitability, with a 1344.85% increase in profit. The company's net worth Soared by an impressive increase of 121.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sattva Pharmaceuticals?
In 2021, Sattva Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- The Reliance Investment Company Private LimitedActive 58 years 6 months
Shyam Ruia and Chandra Ruia are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sattva Pharmaceuticals?
Unlock and access historical data on people associated with Sattva Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sattva Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sattva Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
